By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Memphis, Tenn.-based biomarker development shop Computable Genomix today said that it has received an investment from venture capital firm Innova Memphis to fund a pilot study that it hopes will result in the development of pharmacogenomic tests.

The study is part of the company's efforts to move away from its former identity as a text-mining firm.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.